Journal of Life Science (생명과학회지)

Korean Society of Life Science (한국생명과학회)
권호 표지
DOI QR코드

DOI QR Code

Effect of a Fibrinolytic Enzyme (BK-17) from Bacillus subtilis on Apoptosis Induction in AGS and T24 Human Carcinoma Cells

인간 암세포인 AGS와 T24에서의 apoptosis 유도에 미치는 Bacillus subtilis 혈전용해효소 BK-17의 영향

  • Baik, Hyun (Amaranth-Cosmetics Co.) ;
  • Seo, Min Jeong (Department of Biotechnology, Dong-A University) ;
  • Kim, Min Jeong (Department of Biotechnology, Dong-A University) ;
  • Lee, Hye Hyeon (Department of Biotechnology, Dong-A University) ;
  • Kang, Byoung Won (Medi-Farm Industrialization Research Center, Dong-A University) ;
  • Park, Jeong Uck (Medi-Farm Industrialization Research Center, Dong-A University) ;
  • Choi, Yung Hyun (Department of Biochemistry, College of Oriental Medicine and Research Institute of Oriental Medicine, Department of Biomaterial Control, Graduate School and Blue-Bio Industry Regional Innovation Center, Dongeui University) ;
  • Seo, Kwon Il (Department of Food Nutrition, Sunchon National University) ;
  • Jeong, Yong Kee (Department of Biotechnology, Dong-A University)
  • 백현 (아마라스화장품(주) 부산) ;
  • 서민정 (동아대학교 생명공학과) ;
  • 김민정 (동아대학교 생명공학과) ;
  • 이혜현 (동아대학교 생명공학과) ;
  • 강병원 (동아대학교 Medi-Farm 산업화 연구사업단) ;
  • 박정욱 (동아대학교 Medi-Farm 산업화 연구사업단) ;
  • 최영현 (동의대학교 한의학과) ;
  • 서권일 (순천대학교 식품영양학과) ;
  • 정영기 (동아대학교 생명공학과)
  • Received : 2013.06.18
  • Accepted : 2013.10.26
  • Published : 2013.10.30
Download PDF
⟨ Previous Next ⟩

Abstract

To investigate the effects of a fibrinolytic enzyme, BK-17, on the growth of human cancer cells, we performed various biochemical experiments, including cell proliferation and viability, and investigated subsequent morphological changes and apoptosis induction. BK-17 treatment of AGS human gastric and T24 human bladder carcinoma cells decreased the viability and the proliferation of the cells in a concentration-dependent manner. Microscopic studies indicated that the antiproliferative effects of the BK-17 treatment were associated with morphological changes, such as membrane shrinking, cell rounding up, and the formation of apoptotic bodies, indicating that BK-17 induced apoptosis in the cell lines. Of note, RT-PCR and Western blotting data indicated that the BK-17 treatment induced the down-regulation of antiapoptotic Bcl-2 members, Bcl-2 and $Bcl-X_L$, and the up-regulation of proapoptotic Bax members, Bax and Bad, in the AGS cells. BK-17-induced apoptosis of AGS cells was involved in the proteolytic activation of caspase-3, caspase-8, and caspase-9. Taken together, these findings suggest that BK-17 is associated with the induction of apoptotic cell death.

인간 암세포의 생육에 미치는 혈전용해효소(BK-1)의 영향을 조사하기 위해, 세포증식, 생존력, 형태변화 및 apoptosis 유도 등을 포함한 여러 가지 생화학적 실험을 하였다. 그 결과, AGS 인간 위장 암세포 및 T24 인간 방광 암세포상에의 BK-17 처리는 그 암세포들의 생존력 및 생율을 농도의존적 방법으로 감소시켰다. 현미경 관찰은, BK-17 처리에 의한 항 생육 효과는 막 수축, 세포의 rounding up, apoptotic bodies와 같은 형태학적 변화를 나타내었다. 특히, RT-PCR과 Western blotting data는, BK-17 처리가 항 apoptosis Bcl-2 군들 특히 Bcl-2, and $Bcl-X_L$의 down-regulation 그리고 AGS 세포에서, apoptosis 촉진 매개체 Bax와 Bad의 up-regulation를 유도했다는 것을 보여주었다. BK-17에 의해 유도된 AGS 세포의 apoptosis는 caspase-3, caspase-8 그리고 caspase-9의 단백질가수분해 활성과 관련이 있었다. 이상의 결과를 볼 때, BK-17은 apoptotic cell death의 유도와 밀접한 관련이 있다는 것을 보여주고 있다.

Keywords

References

  1. Antonsson, B. and Martinou, J. C. 2000. The Bcl-2 protein family. Exp Cell Res 256, 50-57. https://doi.org/10.1006/excr.2000.4839
  2. Cheng, J. Q., Jiang, X., Fraser, M.,Li, M., Dan, H. C., Sun, M. and Tsang, B. K. 2002. Role of X-linked inhibitor of apoptosis protein in chemoresistance in ovarian cancer: possible involvement of the phosphoinositide-3 kinase/Akt pathway, Drug Resist Update 5, 131-146. https://doi.org/10.1016/S1368-7646(02)00003-1
  3. Chiarugi, V., Magneli, L., Cinelli, M. and Basi, G. 1994. Apoptosis and the cell cycle. Cell Mol Biol Res 40, 603-612.
  4. Choi, Y. H., Kong, K. R., Kim, Y. A., Jung,K. O., Kil, J. H., Rhee, S. H. and Park, K. Y. 2003. Induction of Bax and activation of caspases during ${\beta}$-sitosterol-mediated apoptosis in human colon cancer cells. Int J Oncol 23, 1657-1661.
  5. Choi, Y. H., Lee, S. J., Nguyen,P., Jang,J. S., Lee, J., Wu, M. L., Takano, E., Maki, M.,Henkart, P. A. and Trepel, J. B. 1997. Regulation of cyclin D1 by calpain protease. J Biol Chem 272, 28479-28484. https://doi.org/10.1074/jbc.272.45.28479
  6. Evans, V. G. 1993. Multiple pathways to apoptosis. Cell Biol Int 17, 461-476. https://doi.org/10.1006/cbir.1993.1087
  7. Gerschenson, L. E. and Rotello, R. J. 1992. Apoptosis: a different type of cell death. FASEB J 6, 2450-2455.
  8. Holcik, M., Gibsonand, H. and Korneluk, R. G. 2001. XIAP: apoptotic brake and promising therapeutic target. Apoptosis 6, 253-261. https://doi.org/10.1023/A:1011379307472
  9. Jeong, Y. K., Park, J. U., Baek, H., Park, S. H., Kong, I. S., Kim, D. W. and Joo, W. H. 2001. Purification and biochemical characterization of a fibrinolytic enzyme from Bacillus subtilis BK-17. World J Microbiol Biotechnol 17, 89-92. https://doi.org/10.1023/A:1016685411809
  10. Jiang, C, Y., Yang, F. and Cheng, S. H. 2004. Fas ligand gene therapy for vascular intimal hyperplasia. Curr Gene Ther 4, 33-39. https://doi.org/10.2174/1566523044578022
  11. Jurgensmeier, J. M., Xie, Z., Deveraux, Q., Ellerby, L., Bredesen, D. and Reed, J. C. 1998. Bax directly induces release of cytochrome c from isolated mitochondria. Proc Natl Acad Sci USA 95, 4997-5002. https://doi.org/10.1073/pnas.95.9.4997
  12. LaCasse, E. C., Baird, S., Korneluk, R. G. and MacKenzie, A. E. 1998. The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 17, 3247-3259.
  13. Lenaz, G., Bovina, C., Formiggini, G. and Castelli, G. P. 1999. Mitochondria, oxidative stress, and antioxidant defences. Acta Biochim Pol 46, 1-21.
  14. Lieberthal, W., Koh, J. S. and Levine, J. S. 1998. Necrosis and apoptosis in acute renal failure. Semin Nephrol 18, 505-518.
  15. Miyashita, T., Krajewski, S., Krajewska, M., Wang, H. G., Lin, H. K., Liebermann, D. A., Hoffman, B. and Reed, J. C. 1994. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9, 1799-1805.
  16. Nagata, S. and Golstein, P. 1996. The Fas death factor. Science 267, 1449-1456.
  17. Rosse T., Olivier, R., Monney, L., Rager, M., Conus, S., Fellay, I., Jansen, B. and Borner, C. 1998. Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c. Nature 391, 496-499. https://doi.org/10.1038/35160
  18. Salvesen, G. S. and Duckett, C. S. 2002. IAP proteins: blocking the road to death's door. Nat Rev Mol Cell Biol 3, 401-410. https://doi.org/10.1038/nrm830
  19. Schultz, D. R. and Harrington, Jr. W. J. 2003. Apoptosis: programmed cell death at a molecular level. Semin Arthritis Rheum 32, 345-369. https://doi.org/10.1053/sarh.2003.50005
  20. Shi, L., Nishioka, W. K., Th'ng, J., Bradbury, E. M., Litchfield, D. W. and Greenberg, A. H. 1994. Premature p34cdc2 activation required for apoptosis. Science 263, 1143-1145. https://doi.org/10.1126/science.8108732
  21. Zimmermann, K. C., Bonzon, C. and Green, D. R. 2001. The machinery of programmed cell death. Pharmacol Ther 92, 57-70. https://doi.org/10.1016/S0163-7258(01)00159-0